CRP and type 2 diabetes mellitus: In the current study, we aimed to explore the plasma levels of inflammatory markers (Lp-PLA2 mass and activity, CRP, and IL-6) in T2DM with and without MCI, and determine potential predictors of MCI among patients with T2DM.